发明名称 |
METHODS FOR TREATING EYE DISORDERS USING OPIOID RECEPTOR ANTAGONISTS |
摘要 |
The present invention discloses methods for treating eye disorders using opioid receptor antagonists. The methods include the step of administering an effective amount of a topically-administered opioid receptor antagonist in the absence of moxifloxacin. Preferably, the topically-administered opioid receptor antagonist is formulated as a solution. Preferably, the topically-administered opioid receptor antagonist is at least one agent selected from the group consisting of: naltrexone, naloxone, nalmefene, and a pharmaceutically-acceptable salt thereof. Preferably, the effective amount corresponds to a concentration of at least about 10−7 molarity. Preferably, the effective amount is based on a treatment administration of at least once every other day. |
申请公布号 |
US2014213605(A1) |
申请公布日期 |
2014.07.31 |
申请号 |
US201313792735 |
申请日期 |
2013.03.11 |
申请人 |
REMEDEYE INC |
发明人 |
Rogosnitzky Moshe |
分类号 |
A61K31/485 |
主分类号 |
A61K31/485 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating anterior segment eye disorders using opioid receptor antagonists, the method comprising the step of:
(a) administering an effective amount of a topically-administered opioid receptor antagonist, in the absence of moxifloxacin, for treating eye disorders affecting the anterior segment of the eye, wherein said topically-administered opioid receptor antagonist is at least one agent selected from the group consisting of: naltrexone, naloxone, nalmefene, and a pharmaceutically-acceptable salt thereof. |
地址 |
New Castle DE US |